Overview

Description

  • NatureSynthetic
  • Amino Acid Sequence
    • SpeciesHuman
    • SequenceThe sequence is proprietary

Associated products

Specifications

Our Abpromise guarantee covers the use of ab48545 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

  • Applications

    Blocking - Blocking peptide for Anti-AVEN antibody - Carboxyterminal end (ab45409)

    Western blot

  • FormLiquid
  • Concentration information loading...

Preparation and Storage

  • Stability and Storage

    Shipped at 4°C. Upon delivery aliquot and store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

    Preservative: 0.02% Sodium Azide
    Constituents: 0.1% BSA, PBS, pH 7.2

General Info

  • Alternative names
    • 1700013A01Rik
    • 1700056A21Rik
    • Apoptosis caspase activation inhibitor
    • AVEN
    • AVEN_HUMAN
    • Cell death regulator Aven
    • mAven L
    • mAven S
    • MGC124011
    • OTTMUSP00000016129
    • PDCD12
    • Programmed cell death 12
    • RP23-52C15.2
    see all
  • FunctionProtects against apoptosis mediated by Apaf-1.
  • Tissue specificityHighly expressed in testis, ovary, thymus, prostate, spleen, small intestine, colon, heart, skeletal muscle, liver, kidney and pancreas.
  • Cellular localizationEndomembrane system. Associated with intracellular membranes.
  • Information by UniProt

References for Human AVEN peptide (ab48545)

ab48545 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab48545.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"